COMPARISM BETWEEN ONCE DAILY AND TWICE DAILY LPV/RTR CO-ADMINISTERED WITH TENOFOVIR AND EMTRICITOBIN AMONG HIV INFECTED PATIENTS DURING MUSLIM RAMADAN

COMPARISM BETWEEN ONCE DAILY AND TWICE DAILY LPV/RTR CO-ADMINISTERED WITH TENOFOVIR AND EMTRICITOBIN AMONG HIV INFECTED PATIENTS DURING MUSLIM RAMADAN FASTING.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201007000226131

Enrollment

100

Registered

2010-06-20

Start date

2010-07-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

Lopinavir/Ritonavir

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -age above 18 years - clinically stable -patint should be on Tenofovir + Emtricytobin+ Lopinavir/ritonavir. -patient that consented.

Exclusion criteria

Exclusion criteria: -Less than 18 year -patient on other ARV regimen -patient that refuse to consent.

Design outcomes

Primary

Measure	Time frame
Tolerability(Presence or Abscence of adverse drug effects);Laboratory monitoring(Lipid profile, Kidney function test, haematocrit);Therapeutic drug monitoring;Adherence	—

Secondary

Measure	Time frame
Effectiveness(Viral load, CD4 count)	—

Countries

Nigeria

Contacts

Public ContactMuhammad Hamza

Senior registrar Infectious and Tropical Diseases

drhamza1020@ymail.com+2348035053139

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026